It is interesting to note that of the nine 1.2 μM MMC(T60)-responsive genes, GPM6A and CDCP1 are tagged with single nucleotide polymorphisms that are shown by CGEMS to be associated with breast cancer risk (P<0.05) (data not shown). This evidence concerns the gene GPM6A and breast cancer.